Substrates for peptidase S21.003: Epstein-Barr virus-type assemblin

Summary Alignment Sequences Sequence features Distribution Structure Literature Substrates Pharma

Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.

Substrate	Uniprot	Residue range	Cleavage Site	Cleavage type	Evidence	P4	P3	P2	P1	P1'	P2'	P3'	P4'	Reference
Assembly protein	P03234	236-605	Peptide-Ala568+Ser-Peptide	P	MU	Leu	Val	Gln	Ala	Ser	Ala	Ser	Gly	Donaghy et al., 1995
Suc-Lys-Lys-Leu-Val-Gln-Ala-Ser-Ala-Ser-NH2			Suc-Lys-Lys-Leu-Val-Gln-Ala+Ser-Ala-Ser-NH2	S		Leu	Val	Gln	Ala	Ser	Ala	Ser	NH2	Jupp et al., 2004
Suc-Ser-Tyr-Val-Lys-Ala-Ser-Val-Ser-NH2			Suc-Ser-Tyr-Val-Lys-Ala+Ser-Val-Ser-NH2	S		Tyr	Val	Lys	Ala	Ser	Val	Ser	NH2	Jupp et al., 2004
Suc-Val-Val-Asn-Ala-Ser-2-aminobutyrate-Arg-NH2			Suc-Val-Val-Asn-Ala+Ser-2-aminobutyrate-Arg-NH2	S		Val	Val	Asn	Ala	Ser	Aba	Arg	NH2	Jupp et al., 2004